• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC NAVIGATION, INC. (LOUISVILLE) STEALTHSTATION S7 SYSTEM NEUROLOGICAL STEREOTAXIC INSTRUMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC NAVIGATION, INC. (LOUISVILLE) STEALTHSTATION S7 SYSTEM NEUROLOGICAL STEREOTAXIC INSTRUMENT Back to Search Results
Model Number S7
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Unspecified Infection (1930); Iatrogenic Source (2498)
Event Date 06/20/2015
Event Type  Injury  
Manufacturer Narrative
The mean age was 63. 6 ± standard error of the mean (sem) 15. 7 years and 60% of patients were males. Patient id's and weight were not provided. Citation: sharma m, deogaonkar m. Accuracy and safety of targeting using intraoperative ¿¿o-arm¿ during placement of deep brain stimulation electrodes without electrophysiological recordings. J clin neurosci (2016), http://dx. Doi. Org/10. 1016/j. Jocn. 2015. 06. 036. No allegation of a product problem. Therefore no evaluation will be performed.
 
Event Description
The aim of the study was to investigate the accuracy of targeting using intraoperative ¿¿o-arm¿ during deep brain stimulation (dbs) surgery. Intraoperative o-arm (medtronic, (b)(4)) images were obtained to confirm the accuracy of placement. The difference between intended and actual target coordinates was calculated based on intraoperative images and postoperative ct scan. Euclidian vector error was obtained to estimate the directional error. Correlation of targeting error with the pneumocephalus and the deviation from the planned trajectory was also estimated. Twenty eight dbs leads (globus pallidus internus [gpi], n
=
13; subthalamic nucleus [stn], n
=
9; ventralis intermedius nucleus [vim], n
=
6) were implanted in 20 patients using the stereotactic leksell frame (elekta (b)(4)) under general anesthesia over a period of 1 year. The mean age was 63. 6 ± standard error of the mean (sem) 15. 7 years and 60% of patients were males. The mean absolute difference (+sem) between intended and actual target in x, y and z coordinates based on intraoperative ct scan was 0. 65 ± 0. 09 (p
=
0. 84), 0. 58 ± 0. 08 (p
=
0. 98), 1. 13 ± 0. 10 (p
=
0. 08), respectively, and postoperative (1 month) ct scan was 0. 82 ± 0. 15 (p
=
0. 89), 0. 55 ± 0. 11 (p
=
0. 97), and 1. 58 ± 0. 29 (p
=
0. 08), respectively. The euclidean vector error was 1. 59 ± 0. 10 and 2. 16 ± 0. 26 based on intraoperative and postoperative images, respectively. There was no statistically significant targeting error based on fusion of intraoperative ct images to either preoperative ct scan or mri as registration series, the presence of pneumocephalus, deviation from planned trajectory or the anatomical target (stn versus vim versus gpi) (p > 0. 05). Superficial skin infection was encountered in a single patient in this study. The mean total operating room time was 193. 5 ± 74. 6 minutes. The distance between two contacts on dbs electrode model 3389 is 2 mm; therefore targeting error of >2 mm implies displacement of approximately one contact and was considered as a threshold for repositioning the lead. None of the dbs electrodes in this study had a displacement of >2 mm requiring repositioning. A single case of superficial infection was noted 3 weeks after the surgery which required removal of the dbs system. Another patient with parkinson¿s disease developed swallowing difficulties secondary to difficult intubation and trauma to the airway following unilateral gpi dbs. She required a percutaneous endoscopic gastrostomy tube and her swallowing function gradually improved over 3 months. No other intraoperative or postoperative complications were encountered in this study patient complications reported are inherent risks to cranial surgery and were not related to use of medtronic system. Conclusion dbs leads can be implanted safely and with accuracy using intraoperative o-arm with a frame based targeting system. Intraoperative o-arm provides three-dimensional accuracy and can be used in selected patients who cannot tolerate awake procedures. Frequent use of this imaging modality is required to master the nuances associated with this technology in the operating room. Randomized controlled studies with large sample size are required to validate the efficacy of intraoperative o-arm during dbs implantation surgery. Medtronic navigation is filing this mdr to ensure visibility to a patient event as a result of a procedure that utilized medtronic navigation's o-arm or stealthstation. There is no allegation to suggest that medtronic navigation's device caused or contributed to the reported event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand NameSTEALTHSTATION S7 SYSTEM
Type of DeviceNEUROLOGICAL STEREOTAXIC INSTRUMENT
Manufacturer (Section D)
MEDTRONIC NAVIGATION, INC. (LOUISVILLE)
826 coal creek circle
louisville CO 80027
Manufacturer (Section G)
MEDTRONIC NAVIGATION, INC. (LOUISVILLE)
826 coal creek circle
louisville CO 80027
Manufacturer Contact
catherine eaton
826 coal creek circle
louisville, CO 80027
7208902092
MDR Report Key5507946
MDR Text Key40592105
Report Number1723170-2016-00371
Device Sequence Number1
Product Code HAW
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K050438
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,literatur
Reporter Occupation Medical Equipment Company Technician/Representative
Type of Report Initial
Report Date 03/17/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/17/2016
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator
Device Model NumberS7
Device Catalogue Number9733856
Was Device Available for Evaluation? No Answer Provided
Is the Reporter a Health Professional? No
Was the Report Sent to FDA?
Event Location No Information
Date Manufacturer Received02/18/2016
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured07/23/2009
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device?
Type of Device Usage Reuse

Patient Treatment Data
Date Received: 03/17/2016 Patient Sequence Number: 1
Treatment
O-ARM 1000 IMAGING SYSTEM
-
-